Ignite Creation Date:
2024-05-05 @ 5:26 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00454961
Status:
COMPLETED
Last Update Posted:
2007-10-25
First Post:
2007-03-30
Brief Title:
Effectiveness of Artemether-Lumefantrine for Malaria Treatment of Children at Community Level in Tanzania
Sponsor:
Karolinska University Hospital
Organization:
Karolinska University Hospital
Study Overview
Official Title:
Effectiveness of Artemether-Lumefantrine Treatment Provided by Community Health Worker Against Uncomplicated Malaria in Children Under 5 Years of Age in Tanzania
Status:
COMPLETED
Status Verified Date:
2007-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
C3
Brief Summary:
The purpose of this clinical trial is to assess the effectiveness of artemether-lumefantrine Coartem treatment provided by community health workers against uncomplicated malaria in children under 5 years of age in Kibaha District Tanzania during an extended follow-up of 42 days The hypothesis is that artemether-lumefantrine treatment provided by community health workers will result in less than 85 PCR-corrected parasitological effectiveness by day 42 mainly due to partial non-compliance to full standard 6-dose regimen of the drug
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None